FC
EVH icon

FORA Capital’s Evolent Health EVH Stock Holding History

FORA Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,971
Closed -$337K – 548
2025
Q2 		$337K Sell
29,971
-37,757
-56% -$347K 0.04% 388
2025
Q1 		$641K Buy
67,728
+10,989
+19% +$111K 0.07% 294
2024
Q4 		$638K Buy
+56,739
New +$997K 0.07% 243
2021
Q4 		– Sell
-24,728
Closed -$767K – 362
2021
Q3 		$767K Buy
24,728
+23,569
+2,034% +$566K 0.19% 145
2021
Q2 		$24K Sell
1,159
-4,684
-80% -$93.8K ﹤0.01% 806
2021
Q1 		$118K Sell
5,843
-4,999
-46% -$95.1K 0.04% 382
2020
Q4 		$174K Buy
+10,842
New +$143K 0.03% 540
2020
Q2 		– Sell
-8,160
Closed -$44K – 1025
2020
Q1 		$44K Buy
+8,160
New +$72.9K 0.01% 792

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FORA Capital's EVH Position: Q3 2025 in Review

FORA Capital sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 29,971 shares — an estimated $337K sold.

FORA Capital first reported a position in EVH in Q1 2020 and held it in 8 quarters. The position peaked at $767K in Q3 2021. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • FORA Capital reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
  • FORA Capital sold 29,971 Evolent Health shares in Q3 2025, an estimated $337K.
  • FORA Capital first reported a position in Evolent Health in Q1 2020 and held it in 8 quarters.
  • FORA Capital's Evolent Health position peaked at $767K in Q3 2021.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.